HER2-PET as a Precision Imaging Tool for Treatment With HER2-ADC in HER2-expressing mBC

Clinical trial NCT06830382 · RECRUITING

Trial details

NCT number: NCT06830382
Sponsor: Renske Altena
Status: RECRUITING
Study type: OBSERVATIONAL

Breast Cancer Stage IV HER2-low Breast Cancer Molecular Imaging

Start date: 2025-10-03
Primary completion: 2030-04-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.